Fujifilm Buys Inspirata’s Digital Pathology Assets

CEO SUMMARY: Fujifilm’s acquisition of the digital pathology technologies and clients of Inspirata marks the departure of one early entrant into the digital pathology market. At the same time, executives from Fujifilm Healthcare Americas Corporation discuss why the company is increasing its offerings in digital pathology. AT THE END OF 2022, Fujifilm announced its acquisition …

Fujifilm Buys Inspirata’s Digital Pathology Assets Read More »

To access this post, you must purchase The Dark Report.

Fujifilm Buys Inspirata’s Digital Pathology Assets

Fujifilm execs see similarities between digital path adoption and early implementation of PACS and EHRs

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month